Posted Aug. 14, 2013 at 8:43 p.m.

Premium Lock Chimerix antiviral's phase II results 'encouraging' but company mum on details

Published: 2013-08-14 20:43:45
Updated: 2013-08-14 20:43:45

Print this blog post
Chimerix drug pipeline as cited in IPO filing. Chimerix drug pipeline as cited in IPO filing.

Chimerix antiviral CMX001's phase II results were not statistically significant compared to a placebo. Executives explain why the results are encouraging....

Read More
Read More

WRAL Tech Wire any time: Twitter, Facebook

Copyright 2014 WRAL Tech Wire. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL Tech Wire and WRAL editors. Read more articles…

Please Log In to add a comment.

Best of TechWire Insider

Techwire Inside Partners

OUR INSIDERS

Frank Vinluan
Life science
Dr. Mike Walden
Tech economy
Vivek Wadhwa
Commentary
Scroll